Regulation of STARS and its downstream targets suggest a novel pathway involved in human skeletal muscle hypertrophy and atrophy

Journal of Physiology

Volumn 587, Issue 8, 2009, Pages 1795-1803

  Lamon, Séverine ^a   Wallace, Marita A ^c   Léger, Bertrand ^a,b   Russell, Aaron P ^c  

^a SUVA   (Switzerland)

^b Institut de Recherche en Réadaptation IRR   (Switzerland)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN BINDING PROTEIN; ALPHA ACTIN; MESSENGER RNA; MYOCARDIN RELATED TRANSCRIPTION FACTOR A; MYOCARDIN RELATED TRANSCRIPTION FACTOR B; MYOSIN IIA; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SERUM RESPONSE FACTOR; SOMATOMEDIN C; STRIATED ACTIVATOR OF RHO SIGNALING; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN IIA; NUCLEAR PROTEIN; STRIATED ACTIVATOR OF RHO SIGNALLING PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SEQUENCE; GENE TARGETING; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCLE GROWTH; MUSCLE HYPERTROPHY; MUSCLE STRENGTH; NORMAL HUMAN; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TISSUE STRUCTURE; MUSCLE TISSUE; PATHOPHYSIOLOGY; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; RESISTANCE TRAINING;

ADULT; ANAEROBIC THRESHOLD; ATROPHY; BLOTTING, WESTERN; DNA PRIMERS; DNA-BINDING PROTEINS; HUMANS; HYPERTROPHY; MALE; MICROFILAMENT PROTEINS; MUSCLE, SKELETAL; ONCOGENE PROTEINS, FUSION; OXYGEN CONSUMPTION; PHYSICAL ENDURANCE; PHYSICAL FITNESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTORS; WEIGHT LIFTING;

EID: 65249095210     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2009.168674     Document Type: Article

References (44)

1. Allen DL, Sartorius CA, Sycuro LK & Leinwand LA (2001). Different pathways regulate expression of the skeletal myosin heavy chain genes. J Biol Chem 276, 43524-43533.
2. Allen DL, Weber JN, Sycuro LK & Leinwand LA (2005). Myocyte enhancer factor-2 and serum response factor binding elements regulate fast Myosin heavy chain transcription in vivo. J Biol Chem 280, 17126-17134.
3. Anderson T & Kearney JT (1982). Effects of three resistance training programs on muscular strength and absolute and relative endurance. Res Q Exerc Sport 53, 1-7.
4. Arai A, Spencer JA & Olson EN (2002). STARS, a striated muscle activator of Rho signaling and serum response factor-dependent transcription. J Biol Chem 277, 24453-24459.
5. Baldi JC, Jackson RD, Moraille R & Mysiw WJ (1998). Muscle atrophy is prevented in patients with acute spinal cord injury using functional electrical stimulation. Spinal Cord 36, 463-469.
6. Cai D, Frantz JD, Tawa NE, Melendez PA, Oh B-C, Lidov HGW, Hasselgren P-O, Frontera WR, Lee J, Glass DJ & Shoelson SE (2004). IKK[beta]/ NF-[kappa]B activation causes severe muscle wasting in mice. Cell 119, 285-298.
7. Campos GE, Luecke TJ, Wendeln HK, Toma K, Hagerman FC, Murray TF, Ragg KE, Ratamess NA, Kraemer WJ & Staron RS (2002). Muscular adaptations in response to three different resistance-training regimens: Specificity of repetition maximum training zones. Eur J Appl Physiol 88, 50-60.
8. Carnac G, Primig M, Kitzmann M, Chafey P, Tuil D, Lamb N & Fernandez A (1998). RhoA GTPase and serum response factor control selectively the expression of MyoD without affecting Myf5 in mouse myoblasts. Mol Biol Cell 9, 1891-1902.
9. Carson JA, Schwartz RJ & Booth FW (1996). SRF and TEF-1 control of chicken skeletal alpha-actin gene during slow-muscle hypertrophy. Am J Physiol Cell Physiol 270, C1624-1633.
10. Cen B, Selvaraj A & Prywes R (2004). Myocardin/MKL family of SRF coactivators: Key regulators of immediate early and muscle specific gene expression. J Cell Biochem 93, 74-82.
11. Charvet C, Houbron C, Parlakian A, Giordani J, Lahoute C, Bertrand A, Sotiropoulos A, Renou L, Schmitt A, Melki J, Li Z, Daegelen D & Tuil D (2006). New role for serum response factor in postnatal skeletal muscle growth and regeneration via the interleukin 4 and insulin-like growth factor 1 pathways. Mol Cell Biol 26, 6664-6674.
12. De Bock K, Richter EA, Russell AP, Eijnde BO, Derave W, Ramaekers M, Koninckx E, Leger B, Verhaeghe J & Hespel P (2005). Exercise in the fasted state facilitates fibre type-specific intramyocellular lipid breakdown and stimulates glycogen resynthesis in humans. J Physiol 564, 649-660.
13. Doucet M, Russell AP, Leger B, Debigare R, Joanisse DR, Caron MA, Leblanc P & Maltais F (2007). Muscle Atrophy and Hypertrophy Signalling in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 176, 261-269.
14. Fleck S & Kraemer W (1997). Designing Resistance Training Programs. Human Kinetics, Champaign, IL, USA.
15. Fluck M, Carson JA, Schwartz RJ & Booth FW (1999). SRF protein is upregulated during stretch-induced hypertrophy of rooster ALD muscle. J Appl Physiol 86, 1793-1799.
16. Fluck M & Hoppeler H (2003). Molecular basis of skeletal muscle plasticity-from gene to form and function. Rev Physiol Biochem Pharmacol 146, 159-216.
17. Fluck M, Waxham MN, Hamilton MT & Booth FW (2000). Skeletal muscle Ca(2+)-independent kinase activity increases during either hypertrophy or running. J Appl Physiol 88, 352-358.
18. Glass DJ (2003). Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 5, 87-90.
19. Gordon SE, Fluck M & Booth FW (2001). Selected Contribution: Skeletal muscle focal adhesion kinase, paxillin, and serum response factor are loading dependent. J Appl Physiol 90, 1174-1183.
20. Himeda CL, Ranish JA & Hauschka SD (2008). Quantitative proteomic identification of MAZ as a transcriptional regulator of muscle-specific genes in skeletal and cardiac myocytes. Mol Cell Biol 28, 6521-6535.
21. Hong MH, Sun H, Jin CH, Chapman M, Hu J, Chang W, Burnett K, Rosen J, Negro-Vilar A & Miner JN (2008). Cell-specific activation of the human skeletal alpha-actin by androgens. Endocrinology 149, 1103-1112.
22. Jackson CG, Dickinson AL & Ringel SP (1990). Skeletal muscle fiber area alterations in two opposing modes of resistance-exercise training in the same individual. Eur J Appl Physiol Occup Physiol 61, 37-41.
23. Jagoe RT, Lecker SH, Gomes M & Goldberg AL (2002). Patterns of gene expression in atrophying skeletal muscles: Response to food deprivation. FASEB J 16, 1697-1712.
24. Kuwahara K, Barrientos T, Pipes GC, Li S & Olson EN (2005). Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol Cell Biol 25, 3173-3181.
25. Kuwahara K, Teg Pipes GC, McAnally J, Richardson JA, Hill JA, Bassel-Duby R & Olson EN (2007). Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity. J Clin Invest 117, 1324-1334.
26. Leger B, Cartoni R, Praz M, Lamon S, Deriaz O, Crettenand A, Gobelet C, Rohmer P, Konzelmann M, Luthi F & Russell AP (2006a). Akt signalling through GSK-3{beta}, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy. J Physiol 576, 923-933.
27. Leger B, Derave W, De Bock K, Hespel P & Russell AP (2008). Human Sarcopenia Reveals an Increase in SOCS-3 and Myostatin and a Reduced Efficiency of Akt Phosphorylation. Rejuvenation Res 11, 163-175B.
28. Leger B, Vergani L, Soraru G, Hespel P, Derave W, Gobelet C, D'Ascenzio C, Angelini C & Russell AP (2006b). Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J 20, 583-585.
29. Li S, Czubryt MP, McAnally J, Bassel-Duby R, Richardson JA, Wiebel FF, Nordheim A & Olson EN (2005). Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissue-specific gene deletion in mice. Proc Natl Acad Sci U S A 102, 1082-1087.
30. Liu HW, Halayko AJ, Fernandes DJ, Harmon GS, McCauley JA, Kocieniewski P, McConville J, Fu Y, Forsythe SM, Kogut P, Bellam S, Dowell M, Churchill J, Lesso H, Kassiri K, Mitchell RW, Hershenson MB, Camoretti-Mercado B & Solway J (2003). The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor. Am J Respir Cell Mol Biol 29, 39-47.
31. Mahadeva H, Brooks G, Lodwick D, Chong NW & Samani NJ (2002). ms1, a novel stress-responsive, muscle-specific gene that is up-regulated in the early stages of pressure overload-induced left ventricular hypertrophy. FEBS Lett 521, 100-104.
32. McClung JM, Lee WJ, Thompson RW, Lowe LL & Carson JA (2003). RhoA induction by functional overload and nandrolone decanoate administration in rat skeletal muscle. Pflugers Arch 447, 345-355.
33. McClung JM, Thompson RW, Lowe LL & Carson JA (2004). RhoA expression during recovery from skeletal muscle disuse. J Appl Physiol 96, 1341-1348.
34. Miano JM, Long X & Fujiwara K (2007). Serum Response Factor: Master Regulator of the Actin Cytoskeleton and Contractile Apparatus. Am J Physiol Cell Physiol 292, C70-81.
35. Miralles F, Posern G, Zaromytidou AI & Treisman R (2003). Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 113, 329-342.
36. Rahmani A, Viale F, Dalleau G & Lacour JR (2001). Force/velocity and power/velocity relationships in squat exercise. Eur J Appl Physiol 84, 227-232.
37. Sakuma K, Akiho M, Nakashima H, Akima H & Yasuhara M (2008). Age-related reductions in expression of serum response factor and myocardin-related transcription factor A in mouse skeletal muscles. Biochim Biophys Acta 1782, 453-461.
38. Sakuma K, Nishikawa J, Nakao R, Nakano H, Sano M & Yasuhara M (2003). Serum response factor plays an important role in the mechanically overloaded plantaris muscle of rats. Histochem Cell Biol 119, 149-160.
39. Schiaffino S, Sandri M & Murgia M (2007). Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology (Bethesda) 22, 269-278.
40. Takano H, Komuro I, Oka T, Shiojima I, Hiroi Y, Mizuno T & Yazaki Y (1998). The Rho family G proteins play a critical role in muscle differentiation. Mol Cell Biol 18, 1580-1589.
41. Vergani L, Malena A, Sabatelli P, Loro E, Cavallini L, Magalhaes P, Valente L, Bragantini F, Carrara F, Leger B, Poulton J, Russell AP & Holt IJ (2007). Cultured muscle cells display defects of mitochondrial myopathy ameliorated by anti-oxidants. Brain 130, 2715-2724.
42. Wang DZ, Li S, Hockemeyer D, Sutherland L, Wang Z, Schratt G, Richardson JA, Nordheim A & Olson EN (2002). Potentiation of serum response factor activity by a family of myocardin-related transcription factors. Proc Natl Acad Sci U S A 99, 14855-14860.
43. Widrick JJ, Stelzer JE, Shoepe TC & Garner DP (2002). Functional properties of human muscle fibers after short-term resistance exercise training. Am J Physiol Regul Integr Comp Physiol 283, R408-416.
44. Woelfle J & Rotwein P (2004). In vivo regulation of growth hormone-stimulated gene transcription by STAT5b. Am J Physiol Endocrinol Metab 286, E393-401.